Search by Drug Name or NDC

    NDC 00173-0772-02 LAMICTAL 25 mg/1 Details

    LAMICTAL 25 mg/1

    LAMICTAL is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is LAMOTRIGINE.

    Product Information

    NDC 00173-0772
    Product ID 0173-0772_d15a5607-7757-4f62-9269-154d706b67e9
    Associated GPIs 72600040007225
    GCN Sequence Number 065167
    GCN Sequence Number Description lamotrigine TAB RAPDIS 25 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 23201
    HICL Sequence Number 007378
    HICL Sequence Number Description LAMOTRIGINE
    Brand/Generic Brand
    Proprietary Name LAMICTAL
    Proprietary Name Suffix ODT
    Non-Proprietary Name lamotrigine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, ORALLY DISINTEGRATING
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name LAMOTRIGINE
    Labeler Name GlaxoSmithKline LLC
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022251
    Listing Certified Through 2024-12-31

    Package

    NDC 00173-0772-02 (00173077202)

    NDC Package Code 0173-0772-02
    Billing NDC 00173077202
    Package 1 DOSE PACK in 1 CARTON (0173-0772-02) / 30 TABLET, ORALLY DISINTEGRATING in 1 DOSE PACK
    Marketing Start Date 2009-06-05
    NDC Exclude Flag N
    Pricing Information N/A